ArticleOncotarget2019

PD-L1 checkpoint blockade delivered by retroviral replicating vector confers anti-tumor efficacy in murine tumor models.

Leah A Mitchell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.